Revision of Maryland Minor Consent Law on Human Immunodeficiency Virus Infection Prevention: An Outcome of Advocacy
DOI:
https://doi.org/10.17140/HARTOJ-7-134Keywords:
HIV, Prevention, Pre-exposure prophylaxis, Adolescents, Minor consent lawAbstract
Objectives
To date, only few United States (US) states have explicit regulations that allow minors to independently give consent for human immunodeficiency virus infection (HIV) prevention treatments. This manuscript will reflect upon key advocacy efforts leading to the revision of the Maryland Minor Consent Law, evaluate current human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) prevention laws for minors in U.S. states, and highlight resources for health advocacy.
Methods
Between 2018-2019, public health professionals in Baltimore, Maryland reviewed the Maryland Minor Consent Law and other adolescent consent laws within the U.S. The professionals advocated for a legal review of the gap by the State Senate and the Office of Attorney General.
Results
In May 2019, the public health advocates were successful in their effort for a revision of the Maryland Minor Consent Law to include Treatment for the Prevention of HIV-Consent by minors. Upon their review of all adolescent consent laws within the U.S., they found that only eleven states currently have explicit language indicative of an adolescent’s ability to give consent for pre-exposure prophylaxis (PrEP).
Conclusion
This inquiry can change upstream factors such as laws, regulations, policies and institutional practices.
References
US Preventive Services Task Force, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M. Preexposure prophylaxis for the prevention of HIV infection: US preventive services task force recommendation statement. JAMA. 2019; 321(22): 2203-2213. doi: 10.1001/jama.2019.6390
Centers for Disease Control and Prevention (CDC). HIV in the United States and dependent areas. 2019. Web site. https://www. cdc.gov/hiv/statistics/overview/ataglance.html. Accessed Octo-ber 2, 2020.
Rotheram MJ, Fernandez MI, Lee SJ, Abdalian, SE, Kozina L, Koussa M, et al. Strategies to treat and prevent HIV in the United States for adolescents and young adults: Protocol for a mixed-meth-ods study. JMIR Res Protoc. 2019; 8(1): e10759. doi: 10.2196/10759
Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, Futter-man D. Youth at risk of HIV: The overlooked US HIV preven-tion crisis. Lancet HIV. 2019; 6(5): 275-278. doi: 10.1016/S2352- 3018(19)30037-2
Maryland Department of Health, Center for HIV Surveillance, Epidemiology and Evaluation. Maryland annual HIV epidemio-logical profile 2018. 2019. Web site. https://phpa.health.maryland. gov/OIDEOR/CHSE/Pages/statistics.aspx. Accessed May 20, 2020.
Prevention and Health Promotion Administration, Maryland Department of Health. HIV among youth (ages 13-24) in Mary-Systematic Review | Volume 7 | Number 1| land, 2018. 2019. Web site. https://phpa.health.maryland.gov/ OIDEOR/CHSE/SiteAssets/Pages/statistics/Youth-Fact-Sheet-2019b.pdf. Accessed May 13, 2020.
Hosek S, Celum C, Wilson C, Kapogiannis B, Delany-Moretlwe S, Bekker LG. Preventing HIV among adolescents with oral PrEP: Observations and challenges in the United States and South Africa. J Int AIDS Soc. 2016; 19(7S6): 21107. doi: 10.7448/IAS.19.7.21107
Allen EB, Gordon A, Krakower D, Hsu, K. HIV pre-exposure prophylaxis for adolescents and young adults. Curr Opin Pediatr. 2017; 29(4): 399-406. doi: 10.1097/MOP.0000000000000512
Pike C, Bekker L-G. PrEP: An opportunity to address unmet adolescent health needs. Pediatrics. 2020; 145(1): e20193172. doi:
1542/peds.2019-3172 10. Burda JP. PrEP and our youth: Implications in law and poli-cy. Columbia Journal of Gender and Law. 2016; 30(2): 294-363. doi: 10.2139/ssrn.2641504
Society for Adolescent Health and Medicine (SAHM). HIV pre-exposure prophylaxis medication for adolescents and young adults: A position paper of the society for adolescent health and medicine. J Adolesc Health. 2018; 63: 513-516. doi: 10.1016/j.jado-health.2018.07.021
Moore Q, Paul ME, McGuire AL, Majumder MA. Legal bar-riers to adolescent participation in research about HIV and other sexually transmitted infections. Am J Public Health. 2016; 106(1): 40-44. doi: 10.2105/AJPH.2015.302940
Tanner MR, Miele P, Carter W, Salvant VS, Dunville R, Kapo-giannis BG, et al. Preexposure prophylaxis for prevention of HIV acquisition among adolescents: Clinical considerations. MMWR Recomm Rep. 2020; 69(3): 1-12. doi: 10.15585/mmwr.rr6903a1
Kapogiannis BG, Koenig LJ, Xu J, Mayer KH, Loeb J, Green-berg L, et al. The HIV continuum of care for adolescents and young adults attending 13 Urban US HIV care centers of the NICHD-ATN-CDC-HRSA SMILE collaborative. J Acquir Immune Defic Syndr. 2020; 84(1): 92-100. doi: 10.1097/QAI.0000000000002308
Johnson A, Green E, Phillips G, Macapagal K, Stonehouse P, Greene G. HIV pre-exposure prophylaxis implementation for ado-lescents: Provider perspectives of multi-level barriers and facilita-tors. Journal of Adolescent Health. 2020; 66(2): S129. doi: 10.1016/j. jadohealth.2019.11.258
Aschenbrenner DS. Descovy approved for HIV prexpo-sure prophylaxis. Am J Nurs. 2020; 120(2): 20. doi: 10.1097/01. NAJ.0000654288.99137.49
Gruber F, Lipozenčić J, Kehler T. History of venereal diseases from antiquity to the renaissance. Acta Dermatovenerol Croat. 2015; 23(1): 1-11. Systematic Review | Volume 7 | Number 1| Olateju O et al
Peng R, Gao, K. The model of venereal disease transmission among male homosexuals considering multiple channels. Current Findings of Infectious Diseases. 2019; 2009(01): 1-6.
American Academy of Pediatrics. Adolescent provider tool-kit: Maryland minor consent laws. 2006. Web site. http://www. nccpeds.com/ContinuityModules-Fall/Fall%20Continuity%20 Source%20Materials/Maryland%20Minor%20Consent%20Laws-full.pdf. Accessed May 18, 2020.
Centers for Disease Control and Prevention. Minors' consent laws for HIV and STD services. 2020. Web site. https://www. cdc.gov/hiv/policies/law/states/minors.html. Accessed May 20, 2020.
Centers for Disease Control and Prevention. State laws that ad-dress high-impact HIV prevention efforts. 2020. Web site. https:// www.cdc.gov/hiv/policies/law/states/index.html. Accessed May 20, 2020.
United Healthcare Workers East. Disrupt Maryland’s rates of HIV. Pdf document. n.d. Accessed October 28, 2019.
LegiNation. BillTrack50:MD - SB251. 2019. Web site. https:// www.billtrack50.com/BillDetail/1037726 . Assessed May 15, 2020.
Legiscan. MD HB1183, 2019, regular session. 2019. Web site. https://legiscan.com/MD/bill/HB1183/2019. Accessed May 15, 2020.
FindLaw. California code, family code—FAM § 6926. n.d. Web site. https://codes.findlaw.com/ca/family-code/fam-sect-6926. html. Accessed May 16, 2020.
FindLaw. Colorado revised statutes title 25. Health § 25-4-409. n.d. Web site. https://codes.findlaw.com/co/title-25-health/co-rev-st-sect-25-4-409.html. Accessed May 16, 2020.
State of Delaware. Delaware code online: Title 13—chapter 7, parents and children—subchapter I. General provisions. n.d. Web site. https://delcode.delaware.gov/title13/c007/sc01/index. shtml. Accessed May 16, 2020.
District of Columbia. District of Columbia municipal regula-tions and District of Columbia register. n.d. Web site. https://dcregs. dc.gov/Common/DCMR/RuleDetail.aspx?RuleId=R0016345. Accessed May 16, 2020.
FindLaw. Iowa code title IV. Public health [Chs. 123-158] § 139A.35. n.d. Web site. https://codes.findlaw.com/ia/title-iv-pub-lic-health-chs-123-158/ia-code-sect-139a-35.html. Accessed May 16, 2020.
FindLaw. Kansas statutes chapter 65. Public health § 65-2892. n.d. Web site. https://codes.findlaw.com/ks/chapter-65-public-health/ks-st-sect-65-2892.html. Accessed May 16, 2020.
FindLaw. Montana title 41. Minors § 41-1-402. n.d. Web site. https://codes.findlaw.com/mt/title-41-minors/mt-code-ann-sect-41-1-402.html. Accessed May 16, 2020.
FindLaw. North Carolina general statutes chapter 90. Medicine and allied occupations § 90-21.5. n.d. Web site. https://codes.find-law.com/nc/chapter-90-medicine-and-allied-occupations/nc-gen-st-sect-90-21-5.html. Accessed May 16, 2020.
Justia US Law. 2014 Oklahoma statutes: Title 63. public health and safety: §63-2602. Right of self-consent under certain condi-tions - doctor patient privileges. n.d. Web site. https://law.justia. com/codes/oklahoma/2014/title-63/section-63-2602/. Accessed May 19, 2020.
Justia US Law. 2016 South Carolina code of laws: Title 63 -South Carolina children’s code: Chapter 5 - legal status of children: Section 63-5-340. Minor’s consent to health services. n.d. Web site. https://law.justia.com/codes/south-carolina/2016/title-63/chap-ter-5/section-63-5-340/. Accessed May 19, 2020.
Dearing JW, Smith DK, Larson RS, Estabrooks CA. Designing for diffusion of a biomedical intervention. Am J Prev Med. 2013; 44(1): S70–S76. doi: 10.1016/j.amepre.2012.09.038
Mullins TLK, Zimet G, Lally M, Kahn JA. Adolescent human immunodeficiency virus care providers’ attitudes toward the use of oral pre-exposure prophylaxis in youth. AIDS Patient Care STDS. 2016; 30(7): 339-348. doi: 10.1089/apc.2016.0048
Traeger MW, Cornelisse VJ, Asselin J. et al. Association of HIV preexposure prophylaxis with incidence of sexually transmitted in-fections among individuals at high risk of HIV infection. JAMA. 2019; 321(14): 1380-1390. doi: 10.1001/jama.2019.2947
Machado DM, de Sant’Anna Carvalho AM, Riera R. Adoles-cent pre-exposure prophylaxis for HIV prevention: Current per-spectives. Adolesc Health Med Ther. 2017; 8: 137-148. doi: 10.2147/ AHMT.S112757
Tolley EE, Li S, Zangeneh SZ, Atujuna M, Musara P, Justman J, et al. Acceptability of a long-acting injectable HIV prevention product among US and African women: Findings from a phase 2 clinical Trial (HPTN 076). J Int AIDS Soc. 2019; 22(10): e25408. Submit your article to this journal | https://openventio.org/submit-manuscript/ 17 Olateju O et al doi: 10.1002/jia2.25408
Kidman R, Nachman S, Kohler HP. Interest in HIV pre-exposure prophylaxis (PrEP) among adolescents and their caregivers in Malawi. AIDS Care. 2020; 32(2): 23-31. doi: 10.1080/09540121.2020.1742861
Gilead Sciences Inc. What are possible side effects of truvada for prep®? 2019. Web site. https://www.truvada.com/what-is-truvada/side-effects. Accessed May 13, 2020.
Gilead Sciences Inc. HIV prevention with your pa-tients’ tomorrow in mind. 2020. Web site. https:// w w w. d e s c ov y h c p. c o m / a b o u t - d e s c ov y - f o r- p r e p ? u t m _ medium=cpc&utm_campaign=2020_branded_phase+3_ learn+about+a+gilead+medication_prep+hcp_supporting_ broad&utm_content=prep_kw&utm_term=%2bprep&utm_ source=google&gclid=cjwkcajw5ij2brbdeiwa0frc9ujd2vi9tvq wpr9xqvrfuplmdordyvakbrbgell6tqbud4g42impsrocbjeqavd_ bwe&gclsrc=aw.ds. Accessed May 13, 2020.
US Department of Health & Human Services. What Is Ending the HIV Epidemic: A Plan for America? Website. https://www. hiv.gov/federal-response/ending-the-hiv-epidemic/overview. Ac-cessed October 2, 2020.
Bassett MT. Public health advocacy. Am J Public Health. 2003; 93(8): 1204. doi: 10.2105/AJPH.93.8.1204
Blenner SR, Lang CM, Prelip ML. Shifting the culture around public health advocacy: Training future public health professionals to be effective agents of change. Health Promot Pract. 2017; 18(6): 785-788. doi: 10.1177/1524839917726764
Chapman S. Advocacy in public health: Roles and challenges. Int J Epidemiol. 2001; 30(6): 1226-1232. doi: 10.1093/ije/30.6.1226
Abood S. Influencing health care in the legislative arena. Online J Issues Nurs. 2007; 12(1): 3. doi: 10.3912/OJIN.Vol12No01Man02
Hosek S, Henry-Reid L. PrEP and adolescents: The role of providers in ending the AIDS epidemic. Pediatrics. 2020; 145(1): 1-7. doi: 10.1542/peds.2019-1743 Systematic Review | Volume 7 | Number 1|
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in HIV/AIDS Research and Treatment (HRT) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
